LD-2 disclosure · 1st Quarter - Report
LUNDBECK PHARMACEUTICALS LLC
Client
- Description
- Specialty and Central Nervous System Bio-pharmaceutical manufacturing.
- Location
- Illinois · United States of America
Registrant
- Description
- Government affairs.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._Modernizing and Ensuring PBM Accountability Act.
LobbyistsSHANNON FINLEY · LUKE HATZIS · ANN JABLON · JEFFREY CARROLL · MICHELLE MATHY · JOHN MARTIN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia.
LobbyistsSHANNON FINLEY · LUKE HATZIS · ANN JABLON · JEFFREY CARROLL · MICHELLE MATHY · JOHN MARTIN
TargetedSENATE · HOUSE OF REPRESENTATIVES